Exelixis, Inc.
EXEL · NASDAQ
10/3/2025 | 7/4/2025 | 4/4/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.36 | 0.88 | 0.81 | 0.99 |
| FCF Yield | 2.68% | 0.39% | 1.96% | 2.39% |
| EV / EBITDA | 40.65 | 52.97 | 49.65 | 55.22 |
| Quality | ||||
| ROIC | 7.40% | 7.32% | 5.95% | 4.86% |
| Gross Margin | 96.89% | 96.57% | 96.55% | 96.48% |
| Cash Conversion Ratio | 1.50 | 0.27 | 1.32 | 1.72 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.85% | 9.16% | 11.38% | 10.42% |
| Free Cash Flow Growth | 489.55% | -74.08% | -16.48% | -13.68% |
| Safety | ||||
| Net Debt / EBITDA | -0.77 | 0.06 | 0.02 | -0.16 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.68 | 0.83 | 0.77 | 0.89 |
| Cash Conversion Cycle | 56.59 | 35.50 | -38.80 | -29.09 |